Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC
- PMID: 23954314
- DOI: 10.1053/j.gastro.2013.08.010
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC
Abstract
Background & aims: Mucosal healing might alter midterm and long-term outcomes of patients with Crohn's disease (CD) and has become an important end point in clinical trials. However, the minimal degree of mucosal improvement (endoscopic response) required to alter midterm outcomes is not known. We aimed to determine the best definition of endoscopic response by evaluating data on the Simple Endoscopic Score for Crohn's Disease (SES-CD) and the Crohn's Disease Endoscopic Index of Severity (CDEIS) from the Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease (SONIC trial).
Methods: We analyzed data from 172 patients who participated in the SONIC trial, were found to have endoscopic lesions at baseline, and underwent a second endoscopic examination at week 26 of treatment with infliximab, azathioprine, or both. Mucosal healing was defined as absence of ulcers. A central reader calculated SES-CD and CDEIS results. Different cutoff values were set for endoscopic response based on the SES-CD or CDEIS. The diagnostic ability of these different cutoff values was evaluated using receiver operating characteristic (ROC) curves, positive likelihood ratios (PLR), and negative likelihood ratios (NLR). Corticosteroid-free clinical remission (CFREM) at week 50 was used as a binary classifier.
Results: Based on analyses of ROC curves, PLR, and NLR, endoscopic response was defined as a decrease from baseline in SES-CD of at least 50%. At week 26, mucosal healing and endoscopic response were achieved in 48% and 65% of patients, respectively. Mucosal healing at week 26 was associated with CFREM at week 50, with 56% sensitivity, 65% specificity, a PLR of 1.60, and an NLR of 0.67. Endoscopic response at week 26 was associated with CFREM at week 50, with 74% sensitivity, 48% specificity, a PLR of 1.42, and an NLR of 0.54. Endoscopic response, defined as a decrease from baseline in CDEIS of at least 50%, yielded similar results.
Conclusions: In patients with CD, mucosal healing and endoscopic response (defined as a decrease from baseline in SES-CD or CDEIS of at least 50%) at week 26 of treatment identified those most likely to be in CFREM at week 50. The ability of the proposed endoscopic response cutoff value to predict midterm CFREM should be validated in an independent, prospective cohort. Its correlation with changes in long-term disease progression still needs to be demonstration. ClinicalTrials.gov, Number: NCT00094458.
Keywords: AUC; C-reactive protein; CD; CDAI; CDEIS; CFREM; CI; CRP; Crohn's Disease Activity Index; Crohn's Disease Endoscopy Index of Severity; Crohn's disease; IBD; MH; Mucosal Healing; NLR; PLR; Prognosis; REM; RESΔ100; RESΔ70; ROC; Response to Therapy; SES-CD; SMH; SONIC; Simple Endoscopic Score for Crohn's disease; Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease; area under the curve; clinical remission; clinical response with at least a 100-point reduction in Crohn's Disease Activity Index score; clinical response with at least a 70-point reduction in Crohn's Disease Activity Index score; confidence interval; corticosteroid-free clinical remission; mucosal healing; negative likelihood ratio; positive likelihood ratio; receiver operating characteristic; segmental mucosal healing.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Implementation of the simple endoscopic activity score in crohn's disease.Saudi J Gastroenterol. 2016 May-Jun;22(3):183-91. doi: 10.4103/1319-3767.182455. Saudi J Gastroenterol. 2016. PMID: 27184635 Free PMC article. Review.
-
Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.Gastroenterology. 2014 Feb;146(2):374-82.e1. doi: 10.1053/j.gastro.2013.10.055. Epub 2013 Oct 29. Gastroenterology. 2014. PMID: 24177375 Clinical Trial.
-
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.Gut. 2014 Jan;63(1):88-95. doi: 10.1136/gutjnl-2013-304984. Epub 2013 Aug 23. Gut. 2014. PMID: 23974954 Clinical Trial.
-
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.Aliment Pharmacol Ther. 2015 Apr;41(8):734-46. doi: 10.1111/apt.13139. Epub 2015 Mar 1. Aliment Pharmacol Ther. 2015. PMID: 25728587 Clinical Trial.
-
Definition and evaluation of mucosal healing in clinical practice.Dig Liver Dis. 2013 Dec;45(12):969-77. doi: 10.1016/j.dld.2013.06.010. Epub 2013 Aug 7. Dig Liver Dis. 2013. PMID: 23932331 Review.
Cited by
-
Vitamin D Deficiency Is Associated with Endoscopic Severity in Patients with Crohn's Disease.Gastroenterol Res Pract. 2017;2017:4869718. doi: 10.1155/2017/4869718. Epub 2017 Nov 16. Gastroenterol Res Pract. 2017. PMID: 29348747 Free PMC article.
-
Endoscopy and cross-sectional imaging for assessing Crohn׳s disease activity.Tech Gastrointest Endosc. 2016 Jul;18(3):123-130. doi: 10.1016/j.tgie.2016.08.001. Tech Gastrointest Endosc. 2016. PMID: 28458507 Free PMC article.
-
Implementation of the simple endoscopic activity score in crohn's disease.Saudi J Gastroenterol. 2016 May-Jun;22(3):183-91. doi: 10.4103/1319-3767.182455. Saudi J Gastroenterol. 2016. PMID: 27184635 Free PMC article. Review.
-
Mucosal Healing in Crohn's Disease: Bull's Eye or Bust? "The Pro Position".Inflamm Intest Dis. 2021 Nov 3;7(1):36-41. doi: 10.1159/000519521. eCollection 2022 Jan. Inflamm Intest Dis. 2021. PMID: 35224016 Free PMC article. Review.
-
Disease monitoring strategies in inflammatory bowel diseases: What do we mean by "tight control"?World J Gastroenterol. 2019 Nov 7;25(41):6172-6189. doi: 10.3748/wjg.v25.i41.6172. World J Gastroenterol. 2019. PMID: 31749591 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous